Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPC-17013995Phase 4Recruiting
Phase 4, open-label, single-arm trial of dexmedetomidine, sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: MOAA/S score and Aldrete score. Started Jan 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPC-17013995.